[breadcrumb_custom]

How To Know If Cardio Diagnostics Holdings Inc (NASDAQ:CDIO) Is Expensive At $1.85.

In last trading session, Cardio Diagnostics Holdings Inc (NASDAQ:CDIO) saw 0.37 million shares changing hands with its beta currently measuring 5.36. Company’s recent per share price level of $1.85 trading at $0.06 or 3.35% at ring of the bell on the day assigns it a market valuation of $37.96M. That closing price of CDIO’s stock is at a discount of -359.46% from its 52-week high price of $8.50 and is indicating a premium of 90.81% from its 52-week low price of $0.17. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.15 million shares which gives us an average trading volume of 6.16 million if we extend that period to 3-months.

Cardio Diagnostics Holdings Inc (NASDAQ:CDIO) trade information

Upright in the green during last session for gaining 3.35%, in the last five days CDIO remained trading in the red while hitting it’s week-highest on Monday, 02/05/24 when the stock touched $1.85 price level, adding 22.92% to its value on the day. Cardio Diagnostics Holdings Inc’s shares saw a change of -25.70% in year-to-date performance and have moved -13.95% in past 5-day. Cardio Diagnostics Holdings Inc (NASDAQ:CDIO) showed a performance of -37.07% in past 30-days. Number of shares sold short was 0.85 million shares which calculate 0.27 days to cover the short interests.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.
Sponsored

Cardio Diagnostics Holdings Inc (CDIO) estimates and forecasts

The company is estimating its revenue growth to decrease by -44.40% in the current quarter and calculating -27.30% decrease in the next quarter.

1 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of $250k for the same. And 1 analysts are in estimates of company making revenue of $1 million in the next quarter that will end on Mar 2024.

CDIO Dividends

Cardio Diagnostics Holdings Inc is more likely to be releasing its next quarterly report in March and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.

On Key

Related Posts